Clinquest Group

From Verify.Wiki
Jump to: navigation, search

Clinquest Group, B.V. based in Amsterdam, The Netherlands, is the parent corporation of a family of companies in the US and Europe that specialize in consulting services for drug discovery and development, implementation, post-approval expertise and compound partnering programs, serving the pharmaceutical, biotechnology, biomedical device and medical data industries.

QuickUpload1085 20170607132234.jpg
http://www.clinquest.com
Type Private
Founded 1998
Slogan Fulfilling the promise of medicine together
Headquarters Amsterdam, The Netherlands
Key people James G. Thomasch

CEO & President, Clinquest Inc.

Cornelis H. Wortel, M.D., Ph.D. CMO, Clinquest Inc.

John M. Naples Chief Financial Officer / Treasurer, Clinquest Inc.

Rolf Jan Rutten, MSc. Managing Director, Clinquest Services BV

Number of employees 11-50 employees

About

Incorporated in 1998, Clinquest is a Healthcare Product Development Service provider specializing in:

  • Pharmacovigilance Services for Investigational and Marketed Products
  • Medical Information Drug Development Consulting
  • Clinical Trial Implementation Data Management and Biostatistics
  • IRT (IVRS/IWRS) for screening, randomization, visit registration and drug supply management

Through our in-house teams and alliances in the US and Europe, we can rapidly assemble virtual pharma teams or integrate into client project teams, providing oversight and expertise to support your individual needs.

Services

  • Clinical Trial Implementation
  • Pharmacovigilance Services for Investigational and Marketed Products
  • Drug Development Consulting
  • Medical Information
  • Data Management and Biostatistics
  • Devices
  • IRT (IVRS/IWRS)


Top 5 Recent Tweets

DateAuthorComment
February 05, 2020pharminewsPharmacovigilance Market Outlook 2019-2026: Accenture, Clinquest Group B.V., Cognizant

https://t.co/Fx4grYc2XA

  1. news #pharma #pharmiweb


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

  1. Pharmacovigilance Market is Anticipated to be Valued at US$ 6,104.1 Mn by 2020 [1]
  2. Accelovance, Inc. Continues European Expansion With Acquisition of THERAMetrics AG's CRO Service[2]

References

  1. https://www.linkedin.com/company-beta/621828/
  2. http://clinquest.com/
  1. https://www.medgadget.com/2017/11/pharmacovigilance-market-is-anticipated-to-be-valued-at-us-6104-1-mn-by-2020.html
  2. https://finance.yahoo.com/news/accelovance-inc-continues-european-expansion-080000648.html

Verification history